I think we all will be just fine in 2019. I anticipate movement on the legalization for medical use front, we need updates on the orphan drug study request, and also know that the cse listing is forthcoming. If someone needs a quick out they likely will have their chance several times in 2019.
These levels are very nice buying prices... I didn't anticipate we would fall this low but obviously a PPShareholder needed some funds. No problems there... just temporary pain and transition of shares/wealth.